Abstract
Background
Plasmablastic lymphoma (PBL) is a relatively new entity, classified by WHO as a rare variant of diffuse large B cell lymphoma. The present case report introduces a 17 year old girl with chronic diarrhea, abdominal pain, intra-abdominal venous thromboses, ascites, mesenteric lymphadenopathies and small intestinal polyposis, the pathologic and immunohistochemistric examinations of the polypoid lesions were in favor of PBL. Numerous cases of PBL have been reported, but to our knowledge, this is the first report of PBL presenting as small intestinal polyposis.Among lymphomas, only mantle cell lymphoma and follicular cell lymphoma have been previously reported to cause intestinal polyposis. This report introduces Plasmablastic lymphoma, a rare variant of diffuse large B cell lymphoma, as a possible cause of small intestinal polyposis.
Keywords: Plasmablastic lymphoma, Small intestine, Polyposis
Case Report
A 17 year old girl with a history of 8-year diarrhea presented with abdominal pain and distention. Her bowel movements had been loose and large in volume, occurring 4-5 times a day, containing no blood or mucus and sometimes making her to wake up for defecation at midnight.
Three months before admission in our hospital, but she referred to another hospital due to abdominal pain and distention, but was self-discharged very soon, without reaching to diagnosis. The only documentations which she brought to us, were a report of an abdominopelvic ultrasonography showing normal liver, biliary tract, spleen, kidneys, ovaries and uterus, but accumulation of ascitic fluid and a suspicious intra-abdominal mass, maximally measuring 24mm in diameter and also, a report of a doppler ultrasonography indicating portal vein and superior mesenteric vein thromboses.
When she referred to our hospital, she was still complaining of abdominal pain and diarrhea. She had lost her appetite but mentioned no weight loss due to edema. She sometimes felt low grade fever without chills or night sweat.
She also complained of amenorrhea. Her first menstrual cycle was at the age of 11 years and then she experienced just 2 other menstrual cycles, the last one being 1 year ago.
She was the 5th child in a family of 6 and was uneducated and single. No other member of her family had a history of chronic diarrhea or any significant disease. She mentioned no close contact to a person with tuberculosis. She did not smoke or use alcohol. Her only medication had been warfarin since 2 months before.
On physical examination, her vital signs were stable. She was conscious, but seemed ill. There were multiple freckles on her tanned face skin but not around her lips or on her buccal mucosa. Also, no aphtous lesion was found in her oral cavity.
Her conjunctiva was pale. There was no temporal wasting. She did not have thyromegaly or distended jugular veins. Also no peripheral lymphadenopathy was found. Her breasts were retarded in growth and she had just breast buds. There was no axillary hair. Her heart and lungs were normal on examination. Her abdomen seemed distended. There was no caput medusa or spider angioma. Her bowel sounds were hyperactive.
She had shifting dullness in her abdomen, suggesting the presence of ascitic fluid, but no mass or hepato/splenomegaly was detected. She had no pubic hair. Her extremities were mildly edematous and clubbing was obvious on her fingers. Laboratory data are shown in table-1.
Table 1. The patient's laboratory data during admission in our hospital.
Test | During admission in our center | Units |
---|---|---|
White Blood Cell (WBC) | 9.6 | 4-10 (×1000/mL) |
Hemoglobin | 6.6 | 12-16 (g/ dL) |
Mean Corpuscular Volume | 62 | 80-100 (fL) |
Platelet | 737 | 150-450 ( /mL ) |
Erythrocyte Sedimentation Rate | 74 | <20 (/ 1st hour) |
Blood Urea Nitrogen | 0.7 | 0.6-1.3 (mg/dL) |
Potassium | 3.1 | 3.5-5.5 (mg/dL) |
Serum Albumin | 2.8 | 3.5-5.3(g/dL) |
Prothrombin Time | 13.3 | 11-13 (sec) |
Partial Thromboplastin Time | 35 | 30-45 (sec) |
Aspartate-amino Transferase | 24 | 0-41 (U/L) |
Alanine-amino Transferase | 30 | 0-37 (U/L) |
Alkaline Phosphatase | 1187 | 64-306 (U/L) |
Lactate Dehydrogenase (LDH) | 593 | 225-500 (U/L) |
Iron | 18 | 50-150 μg/dL |
TIBC | 210 | 300-360 μg/dL |
Ferritin | 11 | 50-200 μg/L |
Stool examination | normal | |
Serum-ascitic albumin gradient | 2.5 | (g/dL) |
She went under upper endoscopy and biopsy from the 2nd part of the duodenum. It grossly revealed hypertensive gastropathy without varix formation, but pathologic examination of the biopsy specimen showed villous atrophy with crypt hyperplasia and severe lymphocytic infiltration. Tests for anti-endomysial IgA, anti-gliadin IgG and anti tissue transglutaminase (anti tTG) IgA and IgG had negative results.
Colonoscopy was also performed, revealing normal macroscopic appearance of mucosa, but no biopsy was taken. An abdominopelvic spiral CT-scan was also performed, showing multiple mesenteric lymphadenopathies and multiple pedunculated polypoid lesions in her small intestine. There was also an oval shaped mass in ileo-jejunal area measuring 60x40mm, causing a non-obstructing intussusception (Figure.1).
At this time, she underwent laparatomy for excisional biopsy of the lymph nodes and resection of the mentioned masses. During the operation, multiple polypoid lesions were found in the small intestinal lumen by touching. One of these polypoid lesions had caused a non-obstructing intussusception at about 100 cm distance from the beginning of the jejunum. Multiple mesenteric lymphadenopathies were also found, but there was no retroperitoneal mass. The intussuscepting mass with 2 adjacent polyps and some lymph nodes were excised for evaluation. Histopathologic examination showed polypoid lesions with ulcerated surface epithelium and destroyed glandular architecture due to diffuse infiltration of discohesive medium to large sized lympho-plasmacytoid neoplastic cells. The tumoral cells had large vesicular nuclei, prominent nucleoli and scant to moderate eosinophilic cytoplasm. Mitotic figures with atypical forms were numerous (Figure-2). All of the excised lymph nodes were also involved by neoplastic cells. The histopathologic fnidings were consistent with lymphoma. The specimens were also evaluated using Immuno-histo-chemical staining. The panel of IHC included leukocyte common antigen (LCA), epidermal membrane antigen (EMA), CD3, CD20, CD79, CD30, CD138, anaplastic large cell lymphoma kinase 1 (ALK 1) and melan A (all from Novocastra). The tumor cells expressed LCA and were positive for EMA, CD138 and CD79, but were negative for CD3, CD20,CD30, ALK 1 and melan A (Figure-2).
All together, the histologic and IHC results were in favor of plasmablastic lymphoma (PBL), but before starting chemotherapy, unfortunately the patient died.
Discussion
In our patient, the presence of chronic diarrhea accompanied by anemia, hypoalbuminemia, delayed puberty and amenorrhea were suggestive of malabsorption.
Iron deficiency anemia in the absence of menstrual cycles necessitated the evaluation of GI tract. Although duodenal biopsy showed lymphocytic infiltration with villous atrophy, these findings were not specific and could be seen in celiac sprue, bacterial overgrowth, crohn s disease, cow s milk protein intolerance (in children), eosinophilic gastroenteritis, giardiasis, lymphoma, peptic duodenitis, tropical sprue, common variable immunodeficiency, autoimmune enteropathy and other immunodeficiency states.(1)
Negative antiendomysial and antigliadin and anti-tTG tests ruled out celiac sprue. In order to search for the other mentioned causes, colonoscopy and evaluation of small intestine were needed.
On the other hand, the presence of high gradient ascites in the absence of heart failure, nephrose or thyroid disease led to ultrasonographic evaluation of the liver and spleen, which subsequently showed intra-abdominal venous thromboses. So, the high gradient ascites seemed to be due to portal hypertension caused by the thromboses. Here, the explanation for the companion of malabsorption and thrombosis could be hyperhomocysteinemia due to folic acid deficiency, (2) extraintestinal complication of inflammatory bowel disease, (3) secondary to the presence of an obscure GI malignancy(4) or even thrombosis due to an underlying mass effect.
All together, the etiology of malabsorption had been still undiagnosed until the observation of intraabdominal lymphadenopathies and small intestinal polypoid lesions led to laparatomy and final diagnosis of lymphoma.
The unique feature of our case was presentation of PBL as small intestinal polyposis. The common small intestinal polyposis syndromes include juvenile polyposis,(5) Peutz-Jeghers syndrome,(5) neurofibromatosis(5) and the less common ones include Cronkhite-Canada syndrome(6) and Cowden syndrome (7) and among non-hudgkin lymphomas, only mantle cell lymphoma (lymphomatous pilyposis) and some cases of follicular lymphoma of the GI tract have been reported with multiple polypoid appearance.(8-10)
PBL is a relatively new entity, classified by WHO as a rare variant of diffuse large B cell lymphoma,(11-12) initially described by Delecluse et al in 1997.(13) It is commonly associated with acquired immunodeficiency syndrome (AIDS), with predilection for the mucosa of oral cavity.(14)
Numerous cases of PBL presenting as buccal mass, cervical lymph node, lung tumor, isolated cutaneous mass, nasopharyngeal lesion, gastric tumor or even after therapy for inflammatory bowel disease, post solid organ transplantation or as a variant of Richter's syndrome have been reported,(12-25) but to our knowledge, this is the first report of PBL presenting as small intestinal polyposis.
According to the pathologic and IHC evaluation, the most important differential diagnoses to be ruled out were anaplastic plasmacytoma/multiple myeloma and anaplastic large cell lymphoma. The immunophenotype of anaplastic plasmacytoma/ multiple myeloma may be similar to that of PBL, but bone marrow involvement is a common finding. Furthermore, the neoplastic cells tend to have a larger cytoplasm and eccentrically located nuclei(18) Negative ALK-1, CD30 and positive CD138 were inconsistent with the diagnosis of anaplastic large cell lymphoma. Besides, tumor cells in anaplastic large cell lymphoma tend to be pleomorphic and bizarre and also plasmacytoid differentiation is not common.(18) Therefore, according to plasmacytoid differentiation, negative CD20 as a conventional B cell marker and strong immunoreactivity for CD138 as a marker of plasmacell differentiation, the diagnosis of PBL was established.
However, due to the aggressive behavior of PBL, the patient's chronic diarrhea could not be explained. Since PBL commonly occurs in immunodeficient patients, especially in association with HIV infection, immunodeficiency could have been the underlying reason for her long lasting diarrhea, but the patient died before the diagnosis of PBL was made. There fore, no test for HIV infection could be performed. It is also possible that another underlying cause, which we could not find, had been responsible for her long lasting diarrhea.
In conclusion, lymphoma should be kept in mind as a cause of small intestinal polyposis. Also, beside mantle cell and follicular lymphomas, this report introduces PBL as a rare but possible cause of small intestinal polyposis.
Footnotes
Conflicts of interest: The authors declare that this manuscript has not been financially supported by any institute or group.
References
- 1.Shah VH, Rotterdam H, Kotler DP, Fasano A, PH G. All that scallops is not celiac disease. Gastrointest Endosc. 2000;51:717–20. doi: 10.1067/mge.2000.104977. [DOI] [PubMed] [Google Scholar]
- 2.Den Heijer M, Koster T, Blom H.J, Bos G.M.J, Briet E, Reitsma P.H, Vandenbroucke J.P, Rosendaal F.R. Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis. N Engl J Med. 1996;334 doi: 10.1056/NEJM199603213341203. [DOI] [PubMed] [Google Scholar]
- 3.Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2005;3:617–28. doi: 10.1016/s1542-3565(05)00154-0. [DOI] [PubMed] [Google Scholar]
- 4.Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer associated venous thromboembolism. J Clin Oncol. 2003;21:4194–9. doi: 10.1200/JCO.2003.05.165. [DOI] [PubMed] [Google Scholar]
- 5.Harned RK, Buck JL, Sobin LH. The hamartomatous polyposis syndromes:clinical and radiologic features. AJR Am J Roentgenol. 1995;164:565–71. doi: 10.2214/ajr.164.3.7863873. [DOI] [PubMed] [Google Scholar]
- 6.Cronkhite LW Jr, WJ. C. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med. 1955;252:1011. doi: 10.1056/NEJM195506162522401. [DOI] [PubMed] [Google Scholar]
- 7.Eng C. Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol. 1998;12:701–10. doi: 10.3892/ijo.12.3.701. [DOI] [PubMed] [Google Scholar]
- 8.Chim CS, Hu WH, Loong F, Ooi GC, Liang R. GI manifestations of mantle cell lymphoma. Gastrointest Endosc. 2003;58:931–3. doi: 10.1016/s0016-5107(03)02235-1. [DOI] [PubMed] [Google Scholar]
- 9.Hashimoto Y, Nakamura N, Kuze T, Ono N, Abe M. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogenous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum Pathol. 1999;30:581–7. doi: 10.1016/s0046-8177(99)90205-8. [DOI] [PubMed] [Google Scholar]
- 10.Isaacson PG, MacLennan KA, Subbuswamy SG. Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology. 1984; 8:64;8:641–56. doi: 10.1111/j.1365-2559.1984.tb02377.x. [DOI] [PubMed] [Google Scholar]
- 11.Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835–49. doi: 10.1200/JCO.1999.17.12.3835. [DOI] [PubMed] [Google Scholar]
- 12.Vega F, Chang CC, Medeiros LJ, Udden M.M, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18:806–15. doi: 10.1038/modpathol.3800355. [DOI] [PubMed] [Google Scholar]
- 13.Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Scheiner U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20. [PubMed] [Google Scholar]
- 14.Flaitz CM, Nichols CM, Walling DM, Hicks MJ. Plasmablastic lymphoma:an HIV-associated entity with primary oral manifestations. Oral Oncol. 2002;38:96–102. doi: 10.1016/s1368-8375(01)00018-5. [DOI] [PubMed] [Google Scholar]
- 15.Gujral S, Shet TM, Kane SV. Morphological spectrum of AIDS-related plasmablastic lymphomas. Indian J Pathol Microbiol. 2008;51:121–4. doi: 10.4103/0377-4929.40423. [DOI] [PubMed] [Google Scholar]
- 16.Hassan A, Kreisel F, Gardner L, Lewis JS, Jr., El-Mofty SK. Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status. Head Neck Pathol. 2007;1:150–5. doi: 10.1007/s12105-007-0006-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jordan LB, Lessells AM, Goodlad JR. Plasmablastic lymphoma arising at a cutaneous site. Histopathology. 2005;46:113–5. doi: 10.1111/j.1365-2559.2005.01985.x. [DOI] [PubMed] [Google Scholar]
- 18.Lin F, Zhang K, Quiery AT, Jr., Prichard J, Schuerch C. Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:581–4. doi: 10.5858/2004-128-581-PLOTCL. [DOI] [PubMed] [Google Scholar]
- 19.Lin Y, Rodrigues GD, Turner JF, Vasef MA. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125:282–5. doi: 10.5858/2001-125-0282-PLOTL. [DOI] [PubMed] [Google Scholar]
- 20.Nguyen DD, Loo BW, Jr., Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH. Plasmablastic lymphoma presenting in a human immunodeficiency virusnegative patient: a case report. Ann Hematol. 2003;82:521–5. doi: 10.1007/s00277-003-0684-3. [DOI] [PubMed] [Google Scholar]
- 21.Nicol I, Boye T, Carsuzaa F, Feier L, Collet Villette AM, Xerri L, Grob JJ, Richard MA. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol. 2003;149:889–91. doi: 10.1046/j.1365-2133.2003.05544.x. [DOI] [PubMed] [Google Scholar]
- 22.Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R. Plasmablastic lymphoma of the stomach. A case report.Haematologica. 1998;83:87–9. [PubMed] [Google Scholar]
- 23.Redmond M, Quinn J, Murphy P, Patchett S, Leader M. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy. J Clin Pathol. 2007;60:80–1. doi: 10.1136/jcp.2006.037556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Robak T, Urbanska-Rys H, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ, Kordek R, Warzocha K. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol. 2001;67:322–7. doi: 10.1034/j.1600-0609.2001.00592.x. [DOI] [PubMed] [Google Scholar]
- 25.Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, Portlock C, Noy A. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIVpositive and -negative patients. Ann Oncol. 2004;15:1673–9. doi: 10.1093/annonc/mdh399. [DOI] [PubMed] [Google Scholar]